Treatment and Relapse of Autoimmune Pancreatitis

키워드

참고문헌 (37)

1. Kim KP, "Autoimmune chronic pancreatitis", Am J Gastroenterol, 99, pp.1605~1616 (2004)
2. Kwon S, "The diagnostic criteria for autoimmune chronic pancreatitis: it is time to make a consensus", Pancreas, 34, pp.279~286 (2007)
3. Chari ST, "Autoimmune pancreatitis, Part II: the relapse", Gastroenterology, 134, pp.625~628 (2008)
4. Kamisawa T, "Morphological changes after steroid therapy in autoimmune pancreatitis", Scand J Gastroenterol, 39, pp.1154~1158 (2004)
5. Song MH, "Regression of pancreatic fibrosis after steroid therapy in patients with autoimmune chronic pancreatitis", Pancreas, 30, pp.83~86 (2005)
6. Church NI, "Autoimmune pancreatitis: clinical and radiological features and objective response to steroid therapy in a UK series", Am J Gastroenterol, 102, pp.2417~2425 (2007)
7. Aithal GP, "High serum IgG4 concentrations in patients with sclerosing pancreatitis", N Engl J Med, 345, pp.147~148 (2001)
8. Frulloni L, "Treating patients with autoimmune pancreatitis: the search for an optimal management continues", Pancreatology, 5, pp.238~240 (2005)
9. Taniguchi T, "Autoimmune pancreatitis detected as a mass in the head of the pancreas without hypergammaglobulinemia, which relapsed after surgery: case report and review of the literature", Dig Dis Sci, 48, pp.1465~1671 (2003)
10. Weber SM, "Lymphoplasmacytic sclerosing pancreatitis: inflammatory mimic of pancreatic carcinoma", J Gastrointest Surg, 7, pp.129~137 (2003)
11. Kamisawa T, "Autoimmune pancreatitis: proposal of IgG4-related sclerosing disease", J Gastroenterol, 41, pp.613~625 (2006)
12. Bjornsson E, "Immunoglobulin G4 associated cholangitis: description of an emerging clinical entity based on review of the literature", Hepatology, 45, pp.1547~1554 (2007)
13. Hirano K, "Long-term prognosis of autoimmune pancreatitis with and without corticosteroid treatment", Gut, 56, pp.1719~1724 (2007)
14. Erkelens GW, "Sclerosing pancreato-cholangitis responsive to steroid therapy", Lancet, 354, pp.43~44 (1999)
15. Ghazale A, "Optimising corticosteroid treatment for autoimmune pancreatitis", Gut, 56, pp.1650~1652 (2007)
16. Chari ST, "Current concepts in the treatment of autoimmune pancreatitis", JOP, 8, pp.1~3 (2007)
17. Chari ST, "Diagnosis of autoimmune pancreatitis: the Mayo Clinic experience", Clin Gastroenterol Hepatol, 4, pp.1010~1016 (2006)
18. Hamano H, "High serum IgG4 concentrations in patients with sclerosing pancreatitis", N Engl J Med, 344, pp.732~738 (2001)
19. Kamisawa T, "Treating patients with autoimmune pancreatitis: results from a long-term follow-up study", Pancreatology, 5, pp.234~238 (2005)
20. Park DH, "Substitution of aspartic acid at position 57 of the DQbeta1 affects relapse of autoimmune pancreatitis", Gastroenterology, 134, pp.440~446 (2008)
21. Ito T, "Treatment for autoimmune pancreatitis: consensus on the treatment for patients with autoimmune pancreatitis in Japan", J Gastroenterol, 42, pp.S50~S58 (2007)
22. Wakabayashi T, "Chronic pancreatitis with diffuse irregular narrowing of the main pancreatic duct", Dig Dis Sci, 43, pp.2415~2425 (1998)
23. Da Silva JA, "Safety of low dose glucocorticoid treatment in rheumatoid arthritis: published evidence and prospective trial data", Ann Rheum Dis, 65, pp.285~293 (2006)
24. Topazian M, "Rituximab therapy for refractory biliary strictures in immunoglobulin G4-associated cholangitis", Clin Gastroenterol Hepatol, 6, pp.364~366 (2008)
25. Wakabayashi T, "Long-term prognosis of duct-narrowing chronic pancreatitis: strategy for steroid treatment", Pancreas, 30, pp.31~39 (2005)
26. Takayama M, "Recurrent attacks of autoimmune pancreatitis result in pancreatic stone formation", Am J Gastroenterol, 99, pp.932~937 (2004)
27. Kawa S, "Clinical features of autoimmune pancreatitis", J Gastroenterol, 42, pp.S9~S14 (2007)
28. Kubota K, "Clinical factors predictive of spontaneous remission or relapse in cases of autoimmune pancreatitis", Gastrointest Endosc, 66, pp.1142~1151 (2007)
29. Ghazale A, "Immunoglobulin G4-associated cholangitis: clinical profile and response to therapy", Gastroenterology, 134, pp.706~715 (2008)
30. Delgado JC, "Pemphigus vulgaris autoantibody response is linked to HLA-DQB1*0503 in Pakistani patients", Hum Immunol, 57, pp.110~119 (1997)
31. Saeki H, "Analysis of disease- associated amino acid epitopes on HLA class II molecules in atopic dermatitis", J Allergy Clin Immunol, 96, pp.1061~1068 (1995)
32. Yunis JJ, "Common major histocompatibility complex class II markers in clinical variants of cicatricial pemphigoid", Proc Natl Acad Sci U S A, 91, pp.7747~7751 (1994)
33. Umemura T, "Association of autoimmune pancreatitis with cytotoxic T-lymphocyte antigen 4 gene polymorphisms in Japanese patients", Am J Gastroenterol, 103, pp.588~594 (2008)
34. Okazaki K, "Are regulatory molecules for T cells involved in the development of autoimmune pancreatitis?", Am J Gastroenterol, 103, pp.595~596 (2008)
35. Ghazale A, "Is autoimmune pancreatitis a risk factor for pancreatic cancer?", Pancreas, 35, pp.376~ (2007)
36. Fukui T, "Pancreatic cancer associated with autoimmune pancreatitis in remission", Intern Med, 47, pp.151~155 (2008)
37. Inoue H, "A case of pancreas cancer with autoimmune pancreatitis", Pancreas, 33, pp.208~209 (2006)

관련 논문AI추천